Selected Publications
Vianzon VV, Hanson RM, Joseph GJ, Garg I, Rogers LM. Rank aggregation of independent genetic screen results highlights new strategies for adoptive cellular transfer therapy of cancer. Front. immunol. 2023 Nov 20. doi: 10.3389/fimmu.2023.1235131.
Muhowski EM, Rogers LM. Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation. Immunohorizons. 2023 May 1;7(5):299-306. doi: 10.4049/immunohorizons.2200062. PubMed PMID: 37129560.
Rogers LM, Wang Z, Mott SL, Dupuy AJ, Weiner GJ. A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors. Cancer Immunol Res. 2020 Sep;8(9):1206-1214. doi: 10.1158/2326-6066.CIR-20-0056. Epub 2020 Jul 1. PubMed PMID: 32611665; PubMed Central PMCID: PMC7483799.
Rogers LM, Mott SL, Smith BJ, Link BK, Sahin D, Weiner GJ. Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy. Clin Cancer Res. 2017 Feb 15;23(4):954-961. doi: 10.1158/1078-0432.CCR-16-1275. Epub 2016 Aug 15. PubMed PMID: 27528699; PubMed Central PMCID: PMC5311060.
Rogers LM, Olivier AK, Meyerholz DK, Dupuy AJ. Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer. J Immunol. 2013 Apr 15;190(8):4393-9. doi: 10.4049/jimmunol.1203227. Epub 2013 Mar 8. PubMed PMID: 23475219; PubMed Central PMCID: PMC3622230.
Rogers LM, Riordan JD, Swick BL, Meyerholz DK, Dupuy AJ. Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer. J Invest Dermatol. 2013 Jul;133(7):1863-9. doi: 10.1038/jid.2013.77. Epub 2013 Feb 20. PubMed PMID: 23426136; PubMed Central PMCID: PMC3672356.